A clinical study of the effects of Zoledronic Acid in the prevention of metastasis of breast cancer to bone, and impact for disease process of breast cancer patients.
Phase of Trial: Phase II
Latest Information Update: 24 Apr 2016
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Breast cancer; Cancer metastases
- Focus Therapeutic Use
- 24 Jul 2014 Status changed from not yet recruiting to completed as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned end date changed from 1 Jan 2010 to 31 Jan 2015 as reported by Chinese Clinical Trial Register.
- 24 Jun 2009 New trial record